Imaging

A new Vanderbilt study is the first to use magnetic resonance imaging (MRI) to noninvasively measure lymphatic flow.

Certain MRI metrics can be used to assess myelin loss in multiple sclerosis, which is important for planning and monitoring therapy.

Daniel Brown, M.D., has been named chief of Interventional Oncology, a new division within the Department of Radiology and Radiological Sciences.

Two new “super-resolution” optical microscopes have put Vanderbilt University Medical Center on the cutting edge of cellular imaging, and are giving researchers their first views of the cell at the molecular level.

Frontiers of Biomedical Imaging Science IV, the fourth bi-annual conference sponsored by the Vanderbilt University Institute of Imaging Science (VUIIS), will be held July 15-18 at the Vanderbilt Student Life Center.

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.

A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.